Innovus Pharmaceuticals Inc (OTCMKTS:INNV) Halts Its Descent

[[tagnumber 0]][[tagnumber 1]]Innovus Pharmaceuticals Inc (OTCMKTS:INNV) is definitely not one of the most traded stocks on the OTC marketplace. In fact, the ticker rarely recorded daily dollar volumes upward of $10 thousand and refused to come above the 10 cent per share mark for quite some time.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]This didn‘t change even after the company filed its financial report for the fiscal 2015. The report came in the end of last month and contained the following numbers of prime interest in its balance sheet.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 9]] [[tagnumber 10]] cash: $56 thousand[[tagnumber 11]] [[tagnumber 10]]current assets: $544 thousand[[tagnumber 11]] [[tagnumber 10]]current liabilities: $2.73 million[[tagnumber 11]] [[tagnumber 10]]annual revenues: $736 thousand[[tagnumber 11]] [[tagnumber 10]]net loss: $4.2 million[[tagnumber 11]] [[tagnumber 20]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]] Despite these rather disturbing numbers we recently saw [[tagnumber 24]]INNV[[tagnumber 25]] climb up the charts and gain impressive value over a very short period of time. Meanwhile, we also saw an impressive increase in daily volumes, despite the lack of press releases.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]][[tagnumber 24]]INNV[[tagnumber 25]] is also being touted by Emerging Markets Consulting. EMC received 600 thousand restricted shares and should receive a further 675 thousand from the company. As the ticker was reaching for 20 cents per share, however, we saw that it was incapable of reaching such highs.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]][[tagnumber 24]]INNV[[tagnumber 25]] suffered a serious loss of nearly 30% in the beginning of this week. Yesterday the company managed to recover some of the lost value and gained 13.64%, closing at $0.125. A total of 1.19 million shares changed their owners and generated $155 thousand in daily dollar volume.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]We see some hesitation in today’s session, so be sure to do your due diligence and weigh out the risks before making any moves on [[tagnumber 24]]INNV.[[tagnumber 25]][[tagnumber 2]]